Effect of long term hormone replacement on plasma prolactin concentrations in women after oophorectomy. 1985

D H Barlow, and G H Beastall, and H I Abdalla, and J Elias-Jones, and R Lindsay, and D M Hart

Plasma prolactin concentrations were studied in 88 oophorectomised women who had been receiving mestranol or placebo for three to 11 years. Thirty one of them were also studied under basal conditions and by tests with thyrotrophin releasing hormone. Under basal conditions the mean prolactin concentration was higher in the oestrogen treated group but under non-rested, clinic conditions the difference was lost because of a rise in prolactin value in the placebo group only. Hence the groups showed a different prolactin response to the mild stress of clinic attendance but the same proportionate responsiveness to thyrotrophin releasing hormone. The data suggest that long term hormone replacement has no significant effect on circulating prolactin concentrations under non-rested, everyday conditions and that the prolactin stimulating effects of minor stress and oestrogen may share a similar mechanism.

UI MeSH Term Description Entries
D007044 Hysterectomy Excision of the uterus. Hysterectomies
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008656 Mestranol The 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yn-17-ol, 3-methoxy-, (17alpha)-,Ethinyl Estradiol 3-Methyl Ether,Ethinyl Estradiol 3 Methyl Ether
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002369 Castration Surgical removal or artificial destruction of gonads. Gonadectomy,Castrations,Gonadectomies
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

D H Barlow, and G H Beastall, and H I Abdalla, and J Elias-Jones, and R Lindsay, and D M Hart
January 1996, Clinical endocrinology,
D H Barlow, and G H Beastall, and H I Abdalla, and J Elias-Jones, and R Lindsay, and D M Hart
January 1997, Gynecologic and obstetric investigation,
D H Barlow, and G H Beastall, and H I Abdalla, and J Elias-Jones, and R Lindsay, and D M Hart
December 1982, British journal of clinical pharmacology,
D H Barlow, and G H Beastall, and H I Abdalla, and J Elias-Jones, and R Lindsay, and D M Hart
July 2002, American journal of obstetrics and gynecology,
D H Barlow, and G H Beastall, and H I Abdalla, and J Elias-Jones, and R Lindsay, and D M Hart
September 1993, Maturitas,
D H Barlow, and G H Beastall, and H I Abdalla, and J Elias-Jones, and R Lindsay, and D M Hart
November 2010, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
D H Barlow, and G H Beastall, and H I Abdalla, and J Elias-Jones, and R Lindsay, and D M Hart
December 2004, Mayo Clinic proceedings,
D H Barlow, and G H Beastall, and H I Abdalla, and J Elias-Jones, and R Lindsay, and D M Hart
January 1988, The Journal of international medical research,
D H Barlow, and G H Beastall, and H I Abdalla, and J Elias-Jones, and R Lindsay, and D M Hart
March 1998, The journals of gerontology. Series A, Biological sciences and medical sciences,
D H Barlow, and G H Beastall, and H I Abdalla, and J Elias-Jones, and R Lindsay, and D M Hart
July 1975, The British journal of psychiatry : the journal of mental science,
Copied contents to your clipboard!